Key points are not available for this paper at this time.
Background: Nanotechnology has emerged as a pivotal domain in material science research with extensive applications across various sectors including biotechnology and medicine. Nanoparticles offer unique properties facilitating advancements in nanobiotechnology, particularly in nanomedicine, to combat bacterial infections and antibiotic resistance. This study aimed to determine the application of nanoparticles, specifically nano-TiO2, in treating plasmid-mediated antibiotic resistance in both Gram-negative and Gram-positive bacteria. Method: We evaluated antibiotic and nanomaterial sensitivity through disc diffusion and broth microdilution assays. Plasmid curing experiments were conducted using varying concentrations of nano-TiO2 and SDS as curing agents, followed by plasmid isolation and DNA extraction. The efficacy of nano-TiO2 in plasmid curing and DNA extraction was assessed, alongside the impact on bacterial growth and antibiotic resistance. Results: Results showed successful plasmid elimination with nano-TiO2 treatment, evidenced by the loss of plasmid DNA bands. Additionally, nano-TiO2 substantially enhanced DNA extraction efficiency and quality. The study indicated nano-TiO2's potential in combating antibiotic resistance by targeting plasmids, thereby presenting a novel approach in molecular biology techniques. Conclusion: In conclusion, this study underscores the promising role of nanoparticles in addressing bacterial infections and combating antibiotic resistance. Nano-TiO2 emerges as a valuable tool in DNA purification and plasmid curing, offering new avenues in molecular biology and antibiotic resistance research. However, further investigations are warranted to elucidate the broader implications of nanoparticles across diverse bacterial species and strains. These findings represent a significant step towards harnessing the potential of nanotechnology in combating antimicrobial resistance and advancing healthcare paradigms.
A Wed, study studied this question.